Dr. Jerome Kim, Director General of IVI (left), standing next to TriLink’s Chief Commercial Officer, Becky Buzzeo, after signing the 'Memorandum of Understanding to Support the Development of ...
Q4 2025 earnings call: revenue beat, positive EBITDA return, and 2026 guidance for growth and margin expansion—read ...
Maravai LifeSciences (NASDAQ:MRVI) executives told investors the company exited fiscal 2025 with improving operating leverage ...
SAN DIEGO--(BUSINESS WIRE)--TriLink BioTechnologies (TriLink®), a Maravai™ LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, is collaborating with the ...
Quantoom’s customers can now access TriLink’s CleanCap mRNA capping technology; Agreement supports future expansion of essential therapeutics & vaccines in developing countries & regions TriLink’s ...
New all-in-one IVT kit can deliver up to 2X more mRNA and up to 85% lower dsRNA compared to other kits on the market through streamlined mRNA synthesis with efficient capping, increased yield, reduced ...
SAN DIEGO, Jan. 7, 2020 /PRNewswire/ -- TriLink BioTechnologies, a Maravai LifeSciences company and a leader in the production of nucleic acids such as DNA and RNA, announced today that the United ...
Lonza customers can now access TriLink’s CleanCap ® mRNA capping technology for non-commercial use, enabling further development of critical mRNA therapeutics SAN DIEGO, April 30, 2024--(BUSINESS WIRE ...
TriLink BioTechnologies, Inc. and Lucigen Corporation have announced that the two companies have signed a licensing agreement for the use of TriLink’s CleanAmp™ dNTPs in Lucigen’s new Taq98™ Hot Start ...
TriLink BioTechnologies (TriLink®), a Maravai LifeSciences company (NASDAQ: MRVI) has announced the grand opening of its new cGMP mRNA manufacturing facility. The 32,000-square-foot facility was ...
TriLink’s CleanCap technology produces optimal 5′ cap structures with over 95% efficiency, creating a co-transcriptional capping solution that dramatically improves mRNA yield and process time when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results